In the eye of the beholder: Evolving etiologies in acute liver failure

Journal of Clinical Gastroenterology

Volumn 38, Issue 8, 2004, Pages 619-620

  Bogin, Vladimir ^a   Marcos, Amadeo ^b   Shaw Stiffel, Thomas ^c  

^a Internal Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLSALICYLIC ACID; ALCOHOL; ALKALINE PHOSPHATASE; ANTICONVULSIVE AGENT; GANCICLOVIR; ISONIAZID; LACTATE DEHYDROGENASE; PARACETAMOL;

ALCOHOL ABUSE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DRUG OVERDOSE; EDITORIAL; EPSTEIN BARR VIRUS; HEPATIC ENCEPHALOPATHY; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; JAUNDICE; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME; SUICIDE ATTEMPT; SYMPTOMATOLOGY; VIRUS HEPATITIS;

HUMANS; LIVER FAILURE, ACUTE;

EID: 4143151628     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000135369.65103.ef     Document Type: Editorial

References (19)

1. Trey C, Davidson LS. The management of fulminant hepatic failure. In: Popper H, Shaffner F, eds. Progress in Liver Disease. New York: Grune and Stratton; 1970:282.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273-275.
3. Ostapowitz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954.
4. Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol. 2000;49:291-301.
5. Caballero F, Lopez-Navidad A, Cotorruelo J, et al. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation. Transplantation. 2002;74:532-537.
6. Jones AL, Simpson KJ. Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther. 1999;13:129-133.
7. Ibranyi E, Schonleber J. Acute liver failure caused by Ecstasy. Orv Hetil. 2003;144:1455-1456.
8. Papaevangelou G. Tassopoulos, Roumeliotou-Karayannis A, et al. Etiology of fulminant viral hepatitis in Greece. Hepatology. 1984;4:369-372.
9. Gocke D. Hepatitis A revisited. Ann Intern Med. 1996;105:960-961.
10. Wilner I, Uhl M, Riely C, et al. Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States. Ann Intern Med. 1998;128:111-114.
11. Brown GR, Persley K. Hepatitis A epidemic in the elderly. South Med J. 2002;95:826-833.
12. Schiødt FV, Davern TA, Shakil O, Acute Liver Failure Study Group. Viral hepatitis-associated acute liver failure. Am J Gastroenterol. 2003;98:448-453.
13. Harma M, Hockerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation. 2003;76:536-539.
14. Aita K, Jin Y, Irie H, et al. Are there histopathologic characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection? A case report and discussion. Hum Pathol. 2001;32:887-889.
15. Ishikawa K, Hasegawa K, Naritomi T, et al. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol. 2002;37:523-530.
16. Li DY, Boitnott JB, Schwarz KB. Human herpes virus-6 (HHV-6): a cause for fulminant hepatic failure or an "innocent bystander." J Pediatr Gastroenterol Nutr. 2003;37:95.
17. Chau TN, Lee KC, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39:302-310.
18. Karetnyi YV, Beck PR, Markin RS. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol. 1999;144:1713.
19. Charlton M, Adjei P, Poterucha J. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 1998;28:839.